Liabilities of RedHill Biopharma Ltd. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
RedHill Biopharma Ltd. quarterly Liabilities in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • RedHill Biopharma Ltd. Liabilities for the quarter ending 31 Dec 2024 was $22,726,000, a 8.3% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

RedHill Biopharma Ltd. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $22,726,000 +$1,748,000 +8.3% 31 Dec 2024 20-F 10 Apr 2025 2024 FY
Q2 2024 $21,963,000 -$9,603,000 -30% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 $20,978,000 -$186,292,000 -90% 31 Dec 2023 20-F 10 Apr 2025 2024 FY
Q2 2023 $31,566,000 -$148,341,000 -82% 30 Jun 2023 6-K 17 Aug 2023 2023 Q2
Q4 2022 $207,270,000 +$34,957,000 +20% 31 Dec 2022 20-F 08 Apr 2024 2023 FY
Q2 2022 $179,907,000 +$5,815,000 +3.3% 30 Jun 2022 6-K 07 Nov 2022 2022 Q2
Q4 2021 $172,313,000 +$5,936,000 +3.6% 31 Dec 2021 20-F 28 Apr 2023 2022 FY
Q2 2021 $174,092,000 +$42,308,000 +32% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 $166,377,000 +$152,280,000 +1080% 31 Dec 2020 20-F 17 Mar 2022 2021 FY
Q2 2020 $131,784,000 +$113,993,000 +641% 30 Jun 2020 6-K 13 Aug 2020 2020 Q2
Q4 2019 $14,097,000 +$2,872,000 +26% 31 Dec 2019 20-F 18 Mar 2021 2020 FY
Q2 2019 $17,791,000 +$5,849,000 +49% 30 Jun 2019 6-K 23 Jul 2019 2019 H1
Q4 2018 $11,225,000 -$1,053,000 -8.6% 31 Dec 2018 20-F 04 Mar 2020 2019 FY
Q2 2018 $11,942,000 30 Jun 2018 6-K 30 Aug 2018 2018 Q2
Q4 2017 $12,278,000 +$767,000 +6.7% 31 Dec 2017 20-F 26 Feb 2019 2018 FY
Q4 2016 $11,511,000 31 Dec 2016 20-F 22 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.